Legal Risks of Enrolling Pregnant Women in Trials Unsupported, Study Finds
June 3, 2024
A new National Academies of Sciences, Engineering and Medicine (NASEM) committee report examines the issues surrounding inclusion of pregnant and lactating women in clinical research and makes a number of recommendations for increasing their participation. In this contribution to The CenterWatch Monthly, report coauthor Bruce Kuhlik, former executive vice president and general counsel for Merck, breaks down its findings.